In addition, by limiting β-catenin activity, FAT4 is also able to reduce the expression of PD-L1 and STT3A and cause abnormal glycosylation and degradation of PD-L1, which may be beneficial for the enhancement of anti-tumor immune responses (Wang et al. 2023a, b). Here, CD274 is linked to neoplasm.